1008119-70-7 Usage
Uses
Used in Organic Synthesis:
3-Fluoro-4-(4-Morpholinylcarbonyl)benzeneboronic acid, 97% is used as a reagent in organic synthesis for its ability to form stable complexes with various organic molecules. This property allows for the creation of new compounds and the modification of existing ones, expanding the scope of organic chemistry.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3-Fluoro-4-(4-Morpholinylcarbonyl)benzeneboronic acid, 97% is used as an intermediate in the synthesis of complex organic compounds. Its unique structure and reactivity make it a valuable building block for the development of new drugs and pharmaceutical agents.
Used in Drug Development:
3-Fluoro-4-(4-Morpholinylcarbonyl)benzeneboronic acid, 97% is used as a key component in the development of novel drugs. Its ability to form stable complexes with organic molecules allows for the design and synthesis of new drug candidates with potential therapeutic benefits.
Used in Biomedical Applications:
In the production of materials for biomedical applications, 3-Fluoro-4-(4-Morpholinylcarbonyl)benzeneboronic acid, 97% is used as a precursor for the synthesis of biocompatible materials. Its unique properties and reactivity contribute to the development of advanced materials for use in medical devices, diagnostics, and therapeutics.
Used in Research and Development:
3-Fluoro-4-(4-Morpholinylcarbonyl)benzeneboronic acid, 97% is also used in research and development for its potential applications in various fields. Its unique chemical properties and reactivity make it an interesting subject for further exploration and innovation.
Check Digit Verification of cas no
The CAS Registry Mumber 1008119-70-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,8,1,1 and 9 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1008119-70:
(9*1)+(8*0)+(7*0)+(6*8)+(5*1)+(4*1)+(3*9)+(2*7)+(1*0)=107
107 % 10 = 7
So 1008119-70-7 is a valid CAS Registry Number.
1008119-70-7Relevant articles and documents
Improving the pharmacokinetic and CYP inhibition profiles of azaxanthene-based glucocorticoid receptor modulators-identification of (S)-5-(2-(9-fluoro-2-(4-(2-hydroxypropan-2-yl)phenyl)-5 H -chromeno[2,3- b ]pyridin-5-yl)-2-methylpropanamido)-N-(tetrahydr
Yang, Michael G.,Dhar, T. G. Murali,Xiao, Zili,Xiao, Hai-Yun,Duan, James J.-W.,Jiang, Bin,Galella, Michael A.,Cunningham, Mark,Wang, Jinhong,Habte, Sium,Shuster, David,McIntyre, Kim W.,Carman, Julie,Holloway, Deborah A.,Somerville, John E.,Nadler, Steven G.,Salter-Cid, Luisa,Barrish, Joel C.,Weinstein, David S.
, p. 4278 - 4290 (2015/06/08)
An empirical approach to improve the microsomal stability and CYP inhibition profile of lead compounds 1a and 1b led to the identification of 5 (BMS-341) as a dissociated glucocorticoid receptor modulator. Compound 5 showed significant improvements in pha
AMINOPYRIDINE DERIVED COMPOUNDS AS LRRK2 INHIBITORS
-
Page/Page column 34, (2014/07/22)
The present invention is directed to aminopyridine derived compounds of formula (A). The compounds are considered useful for the treatment of diseases associated with LRRK2 such a Lewy body dementia, Parkinson's disease or cancer.
FUSED HETEROARYL MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-KB ACTIVITY AND USE THEREOF
-
Page/Page column 103, (2009/10/09)
Novel non-steroidal compounds are provided which are useful in treating diseases or disorders associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity, including metabolic and inflammatory and immune diseases or disorders, ha
